Table 3.

Participant demographic and clinical characteristics.

Participant characteristics	ATB [n = 61]	ORDs [n = 82]	LTBI [n = 24]	HCs [n = 37]
Sex (male); n [%]	48 [79]	61 [74]	7 [34.7]	19 [52.9]
Age (years); median [IQR]	32 [24–37]	42 [31–52]	36 [30–42]	26 [25–31]
Weight (kgs); median [IQR]	50 [46.5–55]	55.6 [48–61]	62.5 [53–71]	62 [58–69]
Having Cough; n [%]	61 [100]	80 [98]	1 [4]	2 [5]
Night sweats; n [%]	42 [69]	61 [74]	2 [8]	1 [3]
Loss of Weight; n [%]	59 [97]	60 [73]	3 [12.5]	0
Smoking; n [%]	19 [31]	23 [28]	1 [4]	5 [13.5]
Firewood cooking; n [%]	5 [8]	18 [22]	2 [8]	2 [5.4]
Alcohol Use; n [%]	23 [38]	33 [40]	4 [16.7]	10 [27]
BCG Vaccine; n [%]	59 [97]	80 [98]	24 [100]	35[94.6]
Treated for TB before; n [%]	11 [18]	16 [20]	1 [4]	0
Can read; n [%]	54 [89]	76 [93]	23 [95.8]	37 [100]
Employed; n [%]	36 [59]	54 [66]	13 [54.2]	19 [51.4]
Married; n [%]	22 [36]	51 [62]	18 [75]	25 [67.6]
HIV Status; n [%] Positive	22 [36]	37 [45]	5 [20.8]	0
Negative	39 [64]	45 [55]	19 [79.2]	37 [100]
CD4 Count (cells/mm3) median [IQR]	220 [140.5-367.5]	323 [218–423.5]	501 [459–563]	NA
IGRA test; n [%] Positive	49 [80]	31 [38]	24 [100]	0
Negative	3 [5]	44 [54]	0	37 [100]
Indeterminate	9 [15]	7 [9]	0	0
RNA Yield (ng/µl); median [IQR]	98.2 [73.4–130]	66.8 [51.9–92.5]	59 [44 -84.6]	91.2 [72.4–117]
Xpert MTB/RIF; n[%] Positive	61 [100]	0	ND	ND
Negative	0	82 [100]
MGIT (positive); n[%] Positive	61 [100]	0	ND	ND
Negative	0	82 [100]

ND = Not done, NA = Not applicable.